Mayo Clinic Proceedings Home

Hostility Predicts Restenosis After Percutaneous Transluminal Coronary Angioplasty


      To investigate the “toxic” total (potential for) hostility component of the type A behavior pattern (assessed by means of the structured interview) as it relates to prediction of restenosis after percutaneous transluminal coronary angioplasty (PTCA).


      Patients with single vessel or multivessel coronary artery disease in whom PTCA had been scheduled or done were administered the structured interview by one trained interviewer prospectively or retrospectively (blinded to angiographic endpoints).

      Material and Methods

      A total of 41 patients underwent 53 initial balloon dilations on native arteries by 1 of 5 participating cardiologists. Inclusion criteria for this study were a successful initial PTCA and post PTCA recatheterization if a patient complained of ischemic symptoms possibly related to restenosis.


      Of the 41 patients, 15 (36.6%) had restenoses at a total of 18 previous angiopiasty sites. Patients with high total (potential for) hostility ratings were almost 2.5 times more likely to have restenosis than those with low total (potential for) hostility scores (95% confidence interval = 1.03 to 5.32). Logistic regression revealed that total (potential for) hostility scores predicted post-PTCA restenosis overall as well as when adjusted for gender and race. Total (potential for) hostility scores were also positively associated with the number of arteries restenosed (P = 0.01).


      This is the first report of type A total (potential for) hostility behavior conferring an increased risk for restenosis after PTCA. Its modification may be effective in reducing recurrent cardiac events. A coronary-prone behavior modification program for patients with persistent, same-site restenosis after PTCA has been initiated.
      CAD (coronary artery disease), MRFIT (Multiple Risk Factor Intervention Trial), PARRFs (postangioplasty restenosis risk factors), PTCA (percutaneous trans luminal coronary angloplasty), SI (structured interview)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Holmes Jr, DR
        • Vlietstra RE
        • Smith HC
        • Vetrovec GW
        • Kent KM
        • Cowley MJ
        • et al.
        Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung and Blood Institute.
        Am J Cardiol. 1984; 53: 77C-81C
        • Bell MR
        • Holmes Jr, DR
        • Berger PB
        • Garratt KN
        • Bailey KR
        • Gersh BJ
        The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty.
        JAMA. 1993; 269: 2091-2095
        • Hermans WR
        • Rensing BJ
        • Strauss BH
        • Serruys PW
        Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a “magic bullet”.
        Am Heart J. 1991; 122: 171-187
        • Ohishi M
        • Fujii K
        • Minamino T
        • Higaki J
        • Kamitani A
        • Rakugi H
        • et al.
        A potent genetic risk factor for restenosis [letter).
        Nat Genet. 1993; 5: 324-325
        • Kop WJ
        • Appels AP
        • Mendes de Leon CF
        • de Swart HB
        • Bar FW
        Vital exhaustion predicts new cardiac events after successful coronary angioplasty.
        Psychosom Med. 1994; 56: 281-287
        • Dembroski TM
        • MacDougall JM
        • Williams RB
        • Haney TL
        • Blumenthal JA
        Components of type A hostility, and anger-in: relationship to angiographic findings.
        Psychosom Med. 1985; 47: 219-233
        • Matthews KA
        • Glass DC
        • Rosenman RH
        • Bortner RW
        Competitive drive, pattern A, and coronary heart disease: a further analysis of some data from the Western Collaborative Group Study.
        J Chronic Dis. 1977; 30: 489-498
        • Dembroski TM
        • Williams RB
        Definition and assessment of coronary-prone behavior.
        in: Schneiderman N Weiss SM Kaufmann PG Handbook of Research Methods in Cardiovascular Behavioral Medicine. Plenum Press,, New York1989: 553-569
        • Leon GR
        • Finn SE
        • Murray D
        • Bailey JM
        Inability to predict cardiovascular disease from hostility scores or MMPI items related to type A behavior.
        J Consult Clin Psychol. 1988; 56: 597-600
        • McCranie EW
        • Watkins LO
        • Brandsma JM
        • Sisson BD
        Hostility, coronary heart disease (CHD) incidence, and total mortality: lack of association in a 25-year follow-up study of 478 physicians.
        J Behav Med. 1986; 9: 119-125
        • Williams Jr, RB
        • Barefoot JC
        • Haney TL
        • Harrell Jr, FE
        • Blumenthal JA
        • Pryor DB
        • et al.
        Type A behavior and angiographically documented coronary atherosclerosis in a sample of 2,289 patients.
        Psychosom Med. 1988; 50: 139-152
        • Rosenman RH
        The interview method of assessment of the coronaryprone behavior pattern.
        in: Dernbroski TM Weiss SM Shields JL Haynes SG Feinleib M Coronary-Prone Behavior. Springer-Verlag, New York1978: 55-70
        • Dembroski TM
        • MacDougall JM
        • Costa Jr, PT
        • Grandits GA
        Components of hostility as predictors of sudden death and myocardial infarction in the Multiple Risk Factor Intervention Trial.
        Psychosom Med. 1989; 51: 514-522
        • MacDougall JM
        • Dembroski TM
        • Dimsdale JE
        • Hackett TP
        Components of type A hostility, and anger-in: further relationships to angiographic findings.
        Health Psychol. 1985; 4: 137-152
        • Hines Jr, EA
        The significance of vascular hyperreaction as measured by the cold-pressor test.
        Am Heart J. 1940; 19: 408-416
        • Hines Jr, EA
        Range of normal blood pressure and subsequent development of hypertension: a follow-up study of 1,522 patients.
        JAMA. 1940; 115: 271-274
        • Menkes MS
        • Matthews KA
        • Krantz DS
        • Lundberg U
        • Mead LA
        • Qaqish B
        • et al.
        Cardiovascular reactivity to the cold pressor test as a predictor of hypertension.
        Hypertension. 1989; 14: 524-530
        • lronson G
        • Taylor CB
        • Boltwood M
        • Bartzokis T
        • Dennis C
        • Chesney M
        • et al.
        Effects of anger on left ventricular ejection fraction in coronary artery disease.
        Am J Cardiol. 1992; 70: 281-285
        • Keys A
        • Taylor HL
        • Blackburn H
        • Brozek J
        • Anderson JT
        • Simonson E
        Mortality and coronary heart disease among men studied for 23 years.
        Arch Intern Med. 1971; 128: 201-214
        • Sloan RP
        • Shapiro PA
        • Bigger Jr, JT
        • Bagiella E
        • Steinman RC
        • Gorman JM
        Cardiac autonomic control and hostility in healthy subjects.
        Am J Cardiol. 1994; 74: 298-300
        • Krantz DS
        • Manuck SB
        Acute psychophysiologic reactivity and risk of cardiovascular disease: a review and methodologic critique.
        Psychol Bull. 1984; 96: 435-464
        • Epstein SE
        • Speir E
        • Unger EF
        • Guzman RJ
        • Finkel T
        The basis of molecular strategies for treating coronary restenosis after angioplasty.
        J Am Coll Cardiol. 1994; 23: 1278-1288
        • Dembroski TM
        • Costa Jr, PT
        Coronary prone behavior: components of the type A pattern and hostility.
        J Pers. 1987; 55: 211-235
        • Shekelle RB
        • Hulley SB
        • Neaton JD
        • Billings JH
        • Borhani NO
        • Gerace TA
        • et al.
        The MRFIT behavior pattern study. II. Type A behavior and incidence of coronary heart disease.
        Am J Epidemiol. 1985; 122: 559-570
      1. Goodman M. Cardiovascular reactivity as a function of a music vs. no-music baseline manipulation. Dissertation, University of Maryland, Baltimore, 1992

        • Allison TG
        • Williams DE
        • Miller TD
        • Patten CA
        • Bailey KR
        • Squires RW
        • et al.
        Medical and economic costs of psychologic distress in patients with coronary artery disease.
        Mayo Clin Proc. 1995; 70: 734-742
        • Glass DC
        • Lake CR
        • Contrada RJ
        • Kehoe K
        • Erlanger LR
        Stability of individual differences in physiologic responses to stress.
        Health Psychol. 1983; 2: 317-341
        • Friedman M
        • Thoresen CE
        • Gill N
        • Ulmer D
        • Powell LH
        • Price VA
        • et al.
        Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the Recurrent Coronary Prevention Project.
        Am Heart J. 1986; 112: 653-665

      Linked Article

      • Identification and Treatment of Psychosocial Risk Factors for Coronary Artery Disease
        Mayo Clinic ProceedingsVol. 71Issue 8
        • Preview
          Since the introduction of the concept of the type A behavior pattern by Friedman and Rosenman in 1959, investigators have had an ongoing interest in the relationship between psychosocial risk factors and the epidemiologic and pathophysiologic features of coronary artery disease. In recent years, emphasis has shifted from attempting to predict the development of coronary artery disease in healthy subjects to evaluating the influence of psychosocial factors on secondary events, health-care costs, and survival in patients with established coronary artery disease.
        • Full-Text
        • PDF